OM vs. SMLR, ELMD, AXGN, EDAP, FONR, VANI, HYPR, ZYXI, OPT, and ACRV
Should you be buying Outset Medical stock or one of its competitors? The main competitors of Outset Medical include Semler Scientific (SMLR), Electromed (ELMD), AxoGen (AXGN), Edap Tms (EDAP), FONAR (FONR), Vivani Medical (VANI), Hyperfine (HYPR), Zynex (ZYXI), Opthea (OPT), and Acrivon Therapeutics (ACRV). These companies are all part of the "medical" sector.
Outset Medical (NASDAQ:OM) and Semler Scientific (NASDAQ:SMLR) are both small-cap medical companies, but which is the better business? We will contrast the two businesses based on the strength of their community ranking, risk, media sentiment, valuation, dividends, institutional ownership, analyst recommendations, earnings and profitability.
Semler Scientific has lower revenue, but higher earnings than Outset Medical. Outset Medical is trading at a lower price-to-earnings ratio than Semler Scientific, indicating that it is currently the more affordable of the two stocks.
In the previous week, Outset Medical had 12 more articles in the media than Semler Scientific. MarketBeat recorded 21 mentions for Outset Medical and 9 mentions for Semler Scientific. Semler Scientific's average media sentiment score of 0.45 beat Outset Medical's score of 0.01 indicating that Semler Scientific is being referred to more favorably in the news media.
49.4% of Semler Scientific shares are held by institutional investors. 3.5% of Outset Medical shares are held by company insiders. Comparatively, 13.0% of Semler Scientific shares are held by company insiders. Strong institutional ownership is an indication that endowments, large money managers and hedge funds believe a stock is poised for long-term growth.
Outset Medical currently has a consensus target price of $5.42, indicating a potential upside of 76.44%. Given Outset Medical's higher possible upside, equities analysts plainly believe Outset Medical is more favorable than Semler Scientific.
Outset Medical received 22 more outperform votes than Semler Scientific when rated by MarketBeat users. Likewise, 37.93% of users gave Outset Medical an outperform vote while only 0.00% of users gave Semler Scientific an outperform vote.
Outset Medical has a beta of 1.85, suggesting that its stock price is 85% more volatile than the S&P 500. Comparatively, Semler Scientific has a beta of 0.92, suggesting that its stock price is 8% less volatile than the S&P 500.
Semler Scientific has a net margin of 32.92% compared to Outset Medical's net margin of -134.93%. Semler Scientific's return on equity of 30.36% beat Outset Medical's return on equity.
Summary
Semler Scientific beats Outset Medical on 10 of the 17 factors compared between the two stocks.
Get Outset Medical News Delivered to You Automatically
Sign up to receive the latest news and ratings for OM and its competitors with MarketBeat's FREE daily newsletter.
This chart shows the number of new MarketBeat users adding OM and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period.
This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.
Outset Medical Competitors List
Related Companies and Tools
